![]() |
|
|
Vol. 297, Issue 2, 804-810, May 2001
Department of Medicine, University of Sydney, Sydney, Australia
(M.M., H.H.R.); Department of Cardiology, Royal North Shore Hospital,
Sydney, Australia (M.M., A.S.M., H.H.R.); Department of Cardiology,
Westmead Hospital, Sydney, Australia (M.M.); and Department of
Pathology, St. Vincents Hospital, Sydney, Australia (A.W.)
Cyclosporine A (CsA) and FK506, important immunosuppressants, have been
shown to inhibit the enzymatic equivalent of the
Na+-K+ pump (Na+,
K+-ATPase) in renal tissue. A similar effect in the
heart may contribute to the adverse effects of these agents that
include calcification, contractile dysfunction, and altered calcium
handling. However, inhibition of the pump has not been demonstrated in
cardiac myocytes. We isolated single ventricular myocytes from control
rabbits and from rabbits administered CsA or FK506 for 1 week.
Na+-K+ pump current (Ip) was
measured using the whole-cell patch-clamp technique. When patch
pipettes contained Na+ in a concentration
([Na]pip) near physiological intracellular levels mean
Ip of cardiac myocytes from rabbits with serum CsA levels
within the therapeutic range was significantly lower than mean
Ip of cardiac myocytes from controls. Treatment had no
effect on Ip measured using a [Na]pip
expected to nearly saturate intracellular binding sites. The
CsA-induced inhibition of Ip was dependent on the
K+ concentration in pipette solutions. Mean Ip
in myocytes from rabbits with serum levels of FK506 within the
therapeutic range was similar to mean Ip in myocytes from
controls, whereas FK506 in a dose inducing serum levels severalfold
above the therapeutic range caused significant pump inhibition. Using
ion-sensitive microelectrodes we showed the intracellular
Na+ activity in papillary muscles isolated from rabbits
treated with CsA was significantly higher than in papillary muscles
from control rabbits, indicating that CsA causes pump inhibition in
intact myocytes with a physiological intracellular milieu.
This article has been cited by other articles:
![]() |
A. S. Mihailidou, M. Mardini, and J. W. Funder Rapid, Nongenomic Effects of Aldosterone in the Heart Mediated by {epsilon} Protein Kinase C Endocrinology, February 1, 2004; 145(2): 773 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. McKenna, S. F. Fraser, J. L. Li, X. N. Wang, M. F. Carey, E. A. Side, J. Morton, G. I. Snell, K. Kjeldsen, and T. J. Williams Impaired muscle Ca2+ and K+ regulation contribute to poor exercise performance post-lung transplantation J Appl Physiol, October 1, 2003; 95(4): 1606 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Mihailidou, M. Mardini, J. W. Funder, and M. Raison Mineralocorticoid and Angiotensin Receptor Antagonism During Hyperaldosteronemia Hypertension, August 1, 2002; 40(2): 124 - 129. [Abstract] [Full Text] [PDF] |
||||